Within3's Insights Update | February 2025
In this issue:
?? Why listening to patients is critical for launch excellence
?? An open-source AI comparison
?? How combining data sources drives better decisions
?? Congress insights reporting: a best practice Q&A
??? Upcoming Events
You can always opt to get updates directly to your email inbox – subscribe here.
Why listening to patients is critical for launch excellence
A successful drug launch isn’t just about strategy—it’s about truly understanding patient needs. Yet, patient voices are often overlooked in the process. Here’s why listening to them is critical for launch excellence:
An open-source AI comparison
Not all AI is created equal—especially in life sciences. While open-source AI has its advantages, it may not be the best fit for pharma’s complex needs. Here’s what to consider:
领英推荐
Integrated insights: how combining data sources drives better decisions
In life sciences, the best decisions come from seeing the full picture. Relying on a single data source can leave gaps in understanding, while integrating multiple sources—like advisory boards, social listening, and real-world data—creates a more complete view. By combining insights across channels, pharma teams can uncover trends, anticipate challenges, and make smarter, faster decisions.
Congress insights reporting: a best practice Q&A
Pharmaceutical congresses generate a wealth of insights, but without the right approach, valuable information can get lost. How can teams efficiently capture, analyze, and act on congress learnings? In this Q&A, experts share best practices for streamlining insights reporting, avoiding common pitfalls, and ensuring key takeaways drive real impact.
“The problem for pharma teams is: how do we make sense of all that data, in real time, while we’re at the congress? How do we report this back to upper management with an action plan in place? How do we assess what to do next?”
Upcoming Events